annual EBITDA:
$20.22B+$13.31B(+192.76%)Summary
- As of today (April 13, 2025), MRK annual EBITDA is $20.22 billion, with the most recent change of +$13.31 billion (+192.76%) on December 1, 2024.
- During the last 3 years, MRK annual EBITDA has risen by +$2.32 billion (+12.97%).
- MRK annual EBITDA is now -18.15% below its all-time high of $24.71 billion, reached on December 31, 2014.
Performance
MRK EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
$4.35B-$1.26B(-22.46%)Summary
- As of today (April 13, 2025), MRK quarterly EBITDA is $4.35 billion, with the most recent change of -$1.26 billion (-22.46%) on December 1, 2024.
- Over the past year, MRK quarterly EBITDA has stayed the same.
- MRK quarterly EBITDA is now -67.92% below its all-time high of $13.55 billion, reached on December 31, 2014.
Performance
MRK quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$24.36B+$5.12B(+26.61%)Summary
- As of today (April 13, 2025), MRK TTM EBITDA is $24.36 billion, with the most recent change of +$5.12 billion (+26.61%) on December 1, 2024.
- Over the past year, MRK TTM EBITDA has stayed the same.
- MRK TTM EBITDA is now -1.41% below its all-time high of $24.71 billion, reached on December 31, 2014.
Performance
MRK TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
MRK EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +192.8% | 0.0% | 0.0% |
| 3 y3 years | +13.0% | 0.0% | 0.0% |
| 5 y5 years | +77.8% | 0.0% | 0.0% |
MRK EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -5.1% | +192.8% | -41.6% | +204.6% | at high | +252.7% |
| 5 y | 5-year | -5.1% | +192.8% | -41.6% | +204.6% | at high | +252.7% |
| alltime | all time | -18.1% | +2009.0% | -67.9% | +204.6% | -1.4% | +2989.2% |
Merck & Co EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $20.22B(+192.8%) | $4.35B(-22.5%) | $24.36B(+26.6%) |
| Sep 2024 | - | $5.61B(-24.7%) | $19.24B(-6.5%) |
| Jun 2024 | - | $7.45B(+7.1%) | $20.58B(+129.2%) |
| Mar 2024 | - | $6.96B(-1001.2%) | $8.98B(+30.0%) |
| Dec 2023 | $6.91B(-67.6%) | -$772.00M(-111.1%) | $6.91B(-43.9%) |
| Sep 2023 | - | $6.95B(-267.3%) | $12.32B(+21.3%) |
| Jun 2023 | - | -$4.16B(-185.1%) | $10.15B(-49.2%) |
| Mar 2023 | - | $4.88B(+5.2%) | $19.97B(-6.3%) |
| Dec 2022 | $21.32B(+19.1%) | $4.64B(-3.1%) | $21.32B(-1.4%) |
| Sep 2022 | - | $4.79B(-15.5%) | $21.63B(-6.2%) |
| Jun 2022 | - | $5.67B(-9.0%) | $23.06B(+15.1%) |
| Mar 2022 | - | $6.22B(+25.7%) | $20.05B(+12.0%) |
| Dec 2021 | $17.90B(+75.8%) | $4.95B(-20.4%) | $17.90B(+55.8%) |
| Sep 2021 | - | $6.22B(+135.0%) | $11.49B(+27.9%) |
| Jun 2021 | - | $2.65B(-35.1%) | $8.99B(-12.5%) |
| Mar 2021 | - | $4.08B(-380.3%) | $10.27B(-7.2%) |
| Dec 2020 | $10.18B(-10.5%) | -$1.46B(-139.2%) | $11.06B(-6.5%) |
| Sep 2020 | - | $3.72B(-5.3%) | $11.82B(+2.5%) |
| Jun 2020 | - | $3.92B(-19.4%) | $11.53B(-4.5%) |
| Mar 2020 | - | $4.87B(-807.0%) | $12.07B(+6.1%) |
| Dec 2019 | $11.37B(-18.7%) | -$689.00M(-120.1%) | $11.37B(-28.3%) |
| Sep 2019 | - | $3.42B(-23.3%) | $15.87B(-3.2%) |
| Jun 2019 | - | $4.46B(+7.0%) | $16.39B(+5.8%) |
| Mar 2019 | - | $4.17B(+9.7%) | $15.50B(+10.8%) |
| Dec 2018 | $13.99B(+17.1%) | $3.81B(-3.6%) | $13.99B(+4.2%) |
| Sep 2018 | - | $3.95B(+10.6%) | $13.42B(+21.8%) |
| Jun 2018 | - | $3.57B(+33.9%) | $11.02B(-2.0%) |
| Mar 2018 | - | $2.67B(-17.6%) | $11.24B(-5.9%) |
| Dec 2017 | $11.95B(+10.4%) | $3.24B(+109.7%) | $11.95B(+37.0%) |
| Sep 2017 | - | $1.54B(-59.3%) | $8.72B(-23.6%) |
| Jun 2017 | - | $3.79B(+12.3%) | $11.41B(+5.2%) |
| Mar 2017 | - | $3.38B(>+9900.0%) | $10.84B(+0.2%) |
| Dec 2016 | $10.82B(-13.1%) | $9.00M(-99.8%) | $10.82B(-19.0%) |
| Sep 2016 | - | $4.23B(+31.2%) | $13.36B(+0.8%) |
| Jun 2016 | - | $3.23B(-3.9%) | $13.26B(+5.0%) |
| Mar 2016 | - | $3.36B(+31.9%) | $12.62B(+1.4%) |
| Dec 2015 | $12.45B(-49.6%) | $2.54B(-38.4%) | $12.45B(-46.9%) |
| Sep 2015 | - | $4.13B(+59.6%) | $23.45B(+3.7%) |
| Jun 2015 | - | $2.59B(-18.6%) | $22.61B(-5.2%) |
| Mar 2015 | - | $3.18B(-76.5%) | $23.86B(-3.4%) |
| Dec 2014 | $24.71B(+85.3%) | $13.55B(+311.6%) | $24.71B(+70.0%) |
| Sep 2014 | - | $3.29B(-14.1%) | $14.54B(-1.0%) |
| Jun 2014 | - | $3.83B(-5.0%) | $14.69B(+5.2%) |
| Mar 2014 | - | $4.03B(+19.3%) | $13.96B(+4.7%) |
| Dec 2013 | $13.33B(-18.8%) | $3.38B(-1.9%) | $13.33B(+1.5%) |
| Sep 2013 | - | $3.44B(+11.1%) | $13.14B(-4.9%) |
| Jun 2013 | - | $3.10B(-9.0%) | $13.81B(-10.1%) |
| Mar 2013 | - | $3.41B(+7.0%) | $15.37B(-6.5%) |
| Dec 2012 | $16.43B(+6.3%) | $3.19B(-22.7%) | $16.43B(-2.6%) |
| Sep 2012 | - | $4.12B(-11.5%) | $16.86B(-1.8%) |
| Jun 2012 | - | $4.66B(+4.1%) | $17.17B(+6.1%) |
| Mar 2012 | - | $4.47B(+23.7%) | $16.19B(+4.7%) |
| Dec 2011 | $15.46B(+58.5%) | $3.62B(-18.4%) | $15.47B(+17.2%) |
| Sep 2011 | - | $4.43B(+20.6%) | $13.19B(+16.6%) |
| Jun 2011 | - | $3.67B(-1.9%) | $11.31B(+2.7%) |
| Mar 2011 | - | $3.75B(+179.3%) | $11.01B(+12.9%) |
| Dec 2010 | $9.75B(-46.8%) | $1.34B(-47.4%) | $9.75B(-40.1%) |
| Sep 2010 | - | $2.55B(-24.4%) | $16.29B(-15.8%) |
| Jun 2010 | - | $3.37B(+35.8%) | $19.34B(+4.4%) |
| Mar 2010 | - | $2.48B(-68.5%) | $18.52B(+1.1%) |
| Dec 2009 | $18.33B(+55.1%) | $7.88B(+40.7%) | $18.33B(+41.7%) |
| Sep 2009 | - | $5.60B(+119.1%) | $12.93B(+40.0%) |
| Jun 2009 | - | $2.56B(+11.8%) | $9.23B(+0.4%) |
| Mar 2009 | - | $2.29B(-8.0%) | $9.19B(-22.2%) |
| Dec 2008 | $11.81B(+55.3%) | $2.49B(+30.6%) | $11.81B(+3.4%) |
| Sep 2008 | - | $1.90B(-24.3%) | $11.42B(+2.3%) |
| Jun 2008 | - | $2.51B(-48.7%) | $11.17B(+5.4%) |
| Mar 2008 | - | $4.91B(+134.1%) | $10.60B(+39.4%) |
| Dec 2007 | $7.61B(+27.7%) | $2.10B(+26.8%) | $7.61B(+19.6%) |
| Sep 2007 | - | $1.65B(-15.0%) | $6.36B(+9.3%) |
| Jun 2007 | - | $1.95B(+1.7%) | $5.82B(-0.2%) |
| Mar 2007 | - | $1.91B(+125.2%) | $5.83B(-2.0%) |
| Dec 2006 | $5.96B(-21.3%) | $849.20M(-23.7%) | $5.96B(-11.7%) |
| Sep 2006 | - | $1.11B(-43.1%) | $6.74B(-10.6%) |
| Jun 2006 | - | $1.96B(-3.7%) | $7.54B(-0.6%) |
| Mar 2006 | - | $2.03B(+24.3%) | $7.59B(+0.2%) |
| Dec 2005 | $7.57B(-7.8%) | $1.64B(-14.7%) | $7.57B(+1.5%) |
| Sep 2005 | - | $1.92B(-4.4%) | $7.46B(+0.9%) |
| Jun 2005 | - | $2.00B(-0.7%) | $7.40B(-7.5%) |
| Mar 2005 | - | $2.02B(+32.3%) | $8.00B(-2.5%) |
| Dec 2004 | $8.21B | $1.53B(-17.7%) | $8.21B(-7.4%) |
| Sep 2004 | - | $1.85B(-29.0%) | $8.87B(-9.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2004 | - | $2.61B(+17.3%) | $9.78B(+1.5%) |
| Mar 2004 | - | $2.22B(+1.9%) | $9.63B(-2.4%) |
| Dec 2003 | $9.88B(-4.2%) | $2.18B(-21.1%) | $9.87B(-6.2%) |
| Sep 2003 | - | $2.77B(+12.2%) | $10.52B(+2.2%) |
| Jun 2003 | - | $2.46B(+0.1%) | $10.29B(-2.4%) |
| Mar 2003 | - | $2.46B(-13.0%) | $10.55B(-0.4%) |
| Dec 2002 | $10.32B(-0.9%) | $2.83B(+11.7%) | $10.59B(+6.9%) |
| Sep 2002 | - | $2.53B(-6.9%) | $9.91B(-4.5%) |
| Jun 2002 | - | $2.72B(+8.7%) | $10.38B(-0.1%) |
| Mar 2002 | - | $2.50B(+16.6%) | $10.39B(-0.2%) |
| Dec 2001 | $10.41B(-2.6%) | $2.15B(-28.5%) | $10.41B(-7.7%) |
| Sep 2001 | - | $3.01B(+10.1%) | $11.28B(+2.5%) |
| Jun 2001 | - | $2.73B(+8.2%) | $11.00B(+1.0%) |
| Mar 2001 | - | $2.52B(-16.2%) | $10.89B(+1.9%) |
| Dec 2000 | $10.69B(+18.0%) | $3.01B(+10.2%) | $10.69B(+3.8%) |
| Sep 2000 | - | $2.73B(+4.4%) | $10.30B(+5.0%) |
| Jun 2000 | - | $2.62B(+13.0%) | $9.81B(+4.5%) |
| Mar 2000 | - | $2.32B(-11.7%) | $9.39B(+3.6%) |
| Dec 1999 | $9.06B(+22.5%) | $2.62B(+16.7%) | $9.06B(+7.1%) |
| Sep 1999 | - | $2.25B(+2.4%) | $8.46B(-1.1%) |
| Jun 1999 | - | $2.20B(+10.4%) | $8.55B(+7.7%) |
| Mar 1999 | - | $1.99B(-1.9%) | $7.94B(+7.4%) |
| Dec 1998 | $7.39B(+10.3%) | $2.03B(-13.4%) | $7.39B(-4.3%) |
| Sep 1998 | - | $2.34B(+47.4%) | $7.73B(+12.8%) |
| Jun 1998 | - | $1.59B(+10.3%) | $6.85B(+0.9%) |
| Mar 1998 | - | $1.44B(-39.0%) | $6.79B(+1.3%) |
| Dec 1997 | $6.70B(+13.3%) | $2.36B(+61.3%) | $6.70B(+4.0%) |
| Sep 1997 | - | $1.46B(-4.0%) | $6.44B(+1.9%) |
| Jun 1997 | - | $1.52B(+12.7%) | $6.32B(+3.2%) |
| Mar 1997 | - | $1.35B(-35.6%) | $6.13B(+3.7%) |
| Dec 1996 | $5.91B(+12.3%) | $2.10B(+56.0%) | $5.91B(+5.2%) |
| Sep 1996 | - | $1.35B(+1.1%) | $5.62B(+2.4%) |
| Jun 1996 | - | $1.33B(+17.4%) | $5.48B(+2.3%) |
| Mar 1996 | - | $1.13B(-37.2%) | $5.36B(+1.9%) |
| Dec 1995 | $5.26B(-0.3%) | $1.81B(+48.9%) | $5.26B(+0.4%) |
| Sep 1995 | - | $1.21B(+0.2%) | $5.24B(+0.0%) |
| Jun 1995 | - | $1.21B(+17.2%) | $5.24B(-0.7%) |
| Mar 1995 | - | $1.03B(-42.2%) | $5.28B(-0.1%) |
| Dec 1994 | $5.28B(+22.8%) | $1.79B(+47.6%) | $5.28B(+0.2%) |
| Sep 1994 | - | $1.21B(-2.8%) | $5.27B(+4.0%) |
| Jun 1994 | - | $1.25B(+20.2%) | $5.07B(+25.6%) |
| Mar 1994 | - | $1.04B(-41.7%) | $4.03B(+3.8%) |
| Dec 1993 | $4.30B(+12.8%) | $1.78B(+76.5%) | $3.89B(+32.0%) |
| Sep 1993 | - | $1.01B(+373.8%) | $2.94B(+4.0%) |
| Jun 1993 | - | $212.40M(-76.1%) | $2.83B(-20.3%) |
| Mar 1993 | - | $890.30M(+6.7%) | $3.55B(+1.7%) |
| Dec 1992 | $3.81B(+13.0%) | $834.40M(-6.5%) | $3.49B(+1.4%) |
| Sep 1992 | - | $892.80M(-4.2%) | $3.44B(+3.1%) |
| Jun 1992 | - | $931.70M(+11.9%) | $3.34B(+1.6%) |
| Mar 1992 | - | $832.60M(+6.1%) | $3.29B(+1.4%) |
| Dec 1991 | $3.37B(+16.1%) | $784.50M(-0.7%) | $3.24B(+3.4%) |
| Sep 1991 | - | $790.40M(-10.2%) | $3.14B(+3.9%) |
| Jun 1991 | - | $880.30M(+11.9%) | $3.02B(+6.5%) |
| Mar 1991 | - | $786.50M(+16.0%) | $2.84B(+6.9%) |
| Dec 1990 | $2.91B(+18.2%) | $678.10M(+0.6%) | $2.65B(+5.0%) |
| Sep 1990 | - | $673.80M(-3.3%) | $2.53B(+3.9%) |
| Jun 1990 | - | $696.80M(+15.6%) | $2.43B(-26.8%) |
| Mar 1990 | - | $602.70M(+9.1%) | $3.32B(-22.6%) |
| Dec 1989 | $2.46B(+18.6%) | $552.40M(-4.7%) | $4.29B(+258.1%) |
| Sep 1989 | - | $579.60M(-63.4%) | $1.20B(-42.6%) |
| Jun 1989 | - | $1.59B(+0.9%) | $2.09B(+4.3%) |
| Mar 1989 | - | $1.57B(-161.9%) | $2.00B(+7.2%) |
| Dec 1988 | $2.07B(+31.2%) | -$2.54B(-272.8%) | $1.87B(-11.4%) |
| Sep 1988 | - | $1.47B(-2.1%) | $2.11B(+8.3%) |
| Jun 1988 | - | $1.50B(+4.4%) | $1.95B(+14.8%) |
| Mar 1988 | - | $1.44B(-162.5%) | $1.69B(+23.8%) |
| Dec 1987 | $1.58B(+27.9%) | -$2.30B(-275.9%) | $1.37B(-20.8%) |
| Sep 1987 | - | $1.31B(+4.6%) | $1.73B(+17.1%) |
| Jun 1987 | - | $1.25B(+12.4%) | $1.48B(+19.8%) |
| Mar 1987 | - | $1.11B(-157.3%) | $1.23B(+18.2%) |
| Dec 1986 | $1.24B(+20.8%) | -$1.94B(-284.0%) | $1.04B(-15.4%) |
| Sep 1986 | - | $1.05B(+4.8%) | $1.23B(+19.2%) |
| Jun 1986 | - | $1.00B(+9.1%) | $1.03B(+14.1%) |
| Mar 1986 | - | $921.10M(-152.6%) | $904.60M(+7.7%) |
| Dec 1985 | $1.02B(+6.6%) | -$1.75B(-304.5%) | $839.80M(+6.5%) |
| Sep 1985 | - | $855.80M(-2.5%) | $788.50M(-0.3%) |
| Jun 1985 | - | $877.40M(+2.5%) | $790.60M(-1.7%) |
| Mar 1985 | - | $856.30M(-147.5%) | $804.50M(+1.0%) |
| Dec 1984 | $958.80M | -$1.80B(-309.9%) | $796.80M(-69.3%) |
| Sep 1984 | - | $857.90M(-3.7%) | $2.60B(+49.3%) |
| Jun 1984 | - | $891.30M(+5.0%) | $1.74B(+105.0%) |
| Mar 1984 | - | $848.60M | $848.60M |
FAQ
- What is Merck & Co annual EBITDA?
- What is the all time high annual EBITDA for Merck & Co?
- What is Merck & Co annual EBITDA year-on-year change?
- What is Merck & Co quarterly EBITDA?
- What is the all time high quarterly EBITDA for Merck & Co?
- What is Merck & Co quarterly EBITDA year-on-year change?
- What is Merck & Co TTM EBITDA?
- What is the all time high TTM EBITDA for Merck & Co?
- What is Merck & Co TTM EBITDA year-on-year change?
What is Merck & Co annual EBITDA?
The current annual EBITDA of MRK is $20.22B
What is the all time high annual EBITDA for Merck & Co?
Merck & Co all-time high annual EBITDA is $24.71B
What is Merck & Co annual EBITDA year-on-year change?
Over the past year, MRK annual EBITDA has changed by +$13.31B (+192.76%)
What is Merck & Co quarterly EBITDA?
The current quarterly EBITDA of MRK is $4.35B
What is the all time high quarterly EBITDA for Merck & Co?
Merck & Co all-time high quarterly EBITDA is $13.55B
What is Merck & Co quarterly EBITDA year-on-year change?
Over the past year, MRK quarterly EBITDA has changed by $0.00 (0.00%)
What is Merck & Co TTM EBITDA?
The current TTM EBITDA of MRK is $24.36B
What is the all time high TTM EBITDA for Merck & Co?
Merck & Co all-time high TTM EBITDA is $24.71B
What is Merck & Co TTM EBITDA year-on-year change?
Over the past year, MRK TTM EBITDA has changed by $0.00 (0.00%)